He
is a specially-appointed expert and associate chief physician at the Advanced
Cancer Specialist Clinic of Hainan
Chengmei
Hospital. He has served as a visiting scholar at Stanford University and San
Francisco Hospital in the United States, and was formerly the director of the
General Surgery and Oncology Center at Baoji Fifth Peoples Hospital. He was
honored as one of the "Top Ten Physicians with Excellent Morality and
Skill" at the second Chinese Physicians Day in Baoji. With 37 years of
experience in clinical work related to surgical malignant tumors, he introduced
the concept of metronomic low-dose chemotherapy immunotherapy (WABO therapy)
from the Cancer Center of the University of Arizona in 2016 and conducted
clinical practical research. He specializes in the treatment of solid malignant
tumors and has treated over a thousand patients with 43 types of tumors across
8 major categories of advanced malignant solid tumors. He has compiled the
"WABO Therapy Treatment Standards and Quality Control Plan" and
achieved a series of original results. He has established the largest clinical
base for WABO therapy in China and is among the first group of clinical
developers and practitioners of WABO therapy in the country.